Cancer

At Our Core

Transforming Trepidation: A Medtech Leader’s Colonoscopy Experience

With March being Colorectal Cancer Awareness Month, Kurt offered to share his recent colonoscopy experience, not only to help raise awareness of the recommended screening age of 45 and the value in knowing your family history, but to acknowledge his own regret about being less than proactive when it came to his health.

Medical Technologies

Illuminating Cancer Cells During Surgery: A Worthy Olympus Investment

On November 16, 2023, Olympus Innovation Ventures (OIV) announced its participation in the $30M Series C funding round to help West Lafayette, Ind. based On Target Laboratories (OTL). The team is working to accelerate commercialization of their novel compound—used in conjunction with near infrared surgical imaging devices.

#Trending

Pancreatic Cancer: From Knowledge Comes Strength

No two patient journeys are the same, but there are common experience threads in these stories from patients diagnosed with pancreatic cancer: unexplained symptoms, a desire for an accurate diagnosis, news that changes their lives, and a relentless pursuit of hope in treatment. We are grateful to all the patients and their families who have shared their journeys, including our latest story about Bob.

#Trending

Let’s Go: Test Your Knowledge of Bladder Cancer Facts

May was bladder cancer awareness month, the perfect time to learn about the frequency of this disease, risk factors, and windows of opportunity for treatment. Take a minute to test your knowledge on cancer that affects this busy storage unit of the urinary tract. Knowledge is always the best defense, so that early detection and treatment are top priority.

Father and son shaking hands after working out.

#Trending

Olympus Marks International Men’s Health Week with Four Myth Busters

International Men’s Health Week is celebrated every year around Father’s Day. This year it will run from June 13-19, 2022, to help increase awareness of preventable health issues and promote early detection and treatment for men of all ages. To support the mission of International Men’s Health Week and provide additional education and promote awareness, below are some common health myths provided with some context to clear up any confusion.

At Our Core

Colonoscopy Prep: Don’t Believe The Hype

I knew that a colonoscopy remained the best option for colorectal cancer screening given its thoroughness and the opportunity to remove any polyps that may have developed. I also knew that provided I would get the all-clear from my physician following the procedure, I wouldn’t need to think about another colonoscopy for a decade. But with the good comes the potentially uncomfortable. ~Ed Sieger

At Our Core

True or False? Six Endometrial Cancer Questions Answered

In the U.S., endometrial cancer—cancer in the lining of the uterus--is the most common gynecologic cancer, based on American Cancer Society data. While there is no standard screening test for uterine cancer, we know enough to list some important facts to help women determine if a symptom is concerning enough to get checked out. Try your hand at these true-or-false statements to learn more.

Medical Technologies

Raising Awareness & Lowering Barriers to Lung Cancer Screenings

Education of both patients and primary care physicians remain key issues in raising lung cancer screening rates along with lowering barriers for patients such as simplifying the shared-decision making process, according to some doctors.

Patient Experience

Mark and Tim Crafts Conquer Cancer Journey: They Keep Rollin'!

“Can I still ride my bike?” was the first question Mark Crafts asked his doctor after his cancer initial diagnosis, and it’s a bit of a wonder that 3 years after the grim diagnosis of Stage IV colorectal and liver cancer, many difficult surgeries and 1,000+ hours of chemo, Mark is still pedaling the byways of the Bay Area.

Research Round-Up

Changing Cancer Treatment at the Cellular Level

What if we told you that the future of medicine is a customized cancer treatment plan for each individual patient, based on their specific genetic, environmental, and lifestyle factors?

Investor Information